Latest News

Rep. Maxine Waters (D-Calif.), a key Democrat and ranking member of the House Financial Services Committee, reportedly plans to walk out of a joint hearing on cryptocurrency policy scheduled for Tuesday.

Markets traded flat on Tuesday as analysts flagged 24,400 as the key level for Nifty’s short-term trajectory.

All sectors except auto, select FMCG, and private bank stocks were in the red.

Morgan Stanley's worst-case scenario analysis showed that the proposed measure would reduce the earnings power of all companies in the value chain.

In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Monday, May 5.

Enjamuri flagged supportive technical indicators and macro tailwinds that could sustain IOC’s upward trend in the near term.

Billionaire investor Bill Ackman believes inflation has largely been "wrung out of the economy" and predicts global economic conflicts could resolve within six to nine months, while advocating for a temporary pause on China tariffs to protect U.S. businesses.

BNB Coin (CRYPTO: BNB) edged higher Monday after asset management giant VanEck filed an exchange-traded fund application with the SEC.

OpenAI, led by Sam Altman, has decided to retain nonprofit control over its for-profit operations, scaling back its transition to a public benefit corporation amid legal pressure and investor demands.

The company’s first-quarter revenue of $738.3 million exceeded Wall Street’s expectations of $708 million.

Investors are optimistic about the company’s prospects, particularly in the multiple sclerosis market, despite challenges from competitors.

Mark Zuckerberg has surpassed Jeff Bezos to become the world's second-richest person, with a net worth of $212 billion, following a surge in Meta's stock price.

The e-commerce companies have raised ad spending, particularly in the UK and France, and are also seeing higher downloads in those regions.

Investors continue to underestimate the artificial intelligence (AI) specialist.

The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline.

​​​​​​​Are you seeing this hidden chart pattern? I hope so, because it tells me this Bear Trap could be one of our easiest winners of the week!

According to Morgan Stanley's Matt Wilson, the 5,750-5,800 area — the convergence of the 200-day and 100-day moving averages — is the most critical technical test for the S&P 500 Index.

The pharma company saw a surge in retail sentiment following its Q1 update, which reaffirmed its 2025 revenue guidance of $900 million to $950 million.

The company projected 2025 oil production between 480,000 and 495,000 barrels of oil equivalent per day, a reduction of 1% at midpoint from its prior forecast.

Volatility in the first quarter increased dramatically ahead of President Trump’s highly anticipated tariff plan. That volatility accelerated at the start of the second quarter, as tariff announcements were significantly worse than expected.

CEO Donnie King said several of its products do not contain dyes and will remove them from the few that do by the end of the month.

The two companies announced plans to expand their autonomous vehicle partnership to 15 additional cities over the next five years, focusing on regions outside the U.S. and China.

Leading cryptocurrencies traded flat on Monday as uncertainty about tariffs calmed investors' risk appetite.

CEO Kyle Gano highlighted record new patient starts for Ingrezza and noted positive early response to the launch of Crenessity, positioning the company for sustained growth.